MLP Saglik Hizmetleri AS (MPARK) fair value: what the stock is really worth
We calculate from audited financials what MLP Saglik Hizmetleri AS is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch MLP Saglik Hizmetleri AS for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
MLP Saglik Hizmetleri A.S. provides healthcare services in Turkey and internationally. It provides treatment, laboratory, and hospital services, as well as trades in medical products. The company was formerly known as Medical Park. MLP Saglik Hizmetleri A.S. was founded in 1993 and is based in Istanbul, Turkey.
Stock analysis
MLP Saglik Hizmetleri AS (MPARK) currently trades at 438.50 TRY, while our model-based Fair Value estimate is 639.90 TRY, implying the stock looks roughly 31.5% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 1,351 TRY per share, and 21 of the 26 models we run sit above the 438.50 TRY price.
Bear case: the Asset-Based group reads lowest at 122.60 TRY, and 5 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: 291.12 TRY (bear) to 799.88 TRY (bull), the price of 438.50 TRY sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
MLP Saglik Hizmetleri AS reported revenue of 55.1B TRY in FY2025 versus 5.8B TRY in FY2021, a compound +75.6%/yr. Reported net income was 5.5B TRY in FY2025, compounding +109.0%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.
Key figures
Market cap 83.5B TRY (≈ $1.7B) · P/E ratio 13.5 · P/S ratio 1.35 · EPS (TTM) 29.72 TRY · Dividend yield 0.3% · Net margin 10.0% · Return on equity 20.6% · Return on assets (EBIT) 17.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 44% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 0% fair-value upside, at 46%, MPARK screens cheaper than that median.
Fair Value models
Bear 291.12 TRYFair Value 639.90 TRYBull 799.88 TRY
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then (21.01 TRY per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+6.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+77.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+68.8%
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+40.5%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 3 years), in TRY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TRY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+55.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+55.2%
Dividend (yield on the price)0.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 18%
Growth Forecast
A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+28.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+20.3%
Yearly sales growth analysts expect, extended to five years.
Compare MLP Saglik Hizmetleri AS with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 257 stocks
Beats the industry median on 9/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score49 · Below median
Fair Value upside+50% · Top 25%
Profitability
Return on equity (TTM)21% · Top 25%
Return on assets10% · Top 25%
Net margin (TTM)10% · Above median
Operating margin (TTM)16% · Top 25%
Growth and dividend
Revenue growth6% · Above median
Dividend yield (TTM)0.3% · Bottom 25%
Balance sheet
Debt / equity0.32× · Above median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "MLP Saglik Hizmetleri AS Fair Value". https://www.fairvalue-calculator.com/stock/MPARK
Frequently asked questions
Is MLP Saglik Hizmetleri AS (MPARK) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 639.90 TRY versus a price of 438.50 TRY, about +46% upside (undervalued).
What is the fair value of MPARK?
Our model-based fair value for MLP Saglik Hizmetleri AS is 639.90 TRY (as of Sep 13, 2026), built from audited fundamentals. The current price: 438.50 TRY.
What is the quality score of MPARK?
MLP Saglik Hizmetleri AS has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MLP Saglik Hizmetleri AS (MPARK)?
Our model-based price target is the fair value of 639.90 TRY (as of Sep 13, 2026) from 26 valuation models. Cautious scenario 291.12 TRY, optimistic scenario 799.88 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the MLP Saglik Hizmetleri AS stock forecast for 2026?
Our models put fair value at 639.90 TRY, about +46% upside versus a price of 438.50 TRY (undervalued). Cautious scenario 291.12 TRY, optimistic scenario 799.88 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of MLP Saglik Hizmetleri AS (MPARK)?
MLP Saglik Hizmetleri AS reported trailing-twelve-month revenue of about 55.1B TRY (latest available figure, as of Sep 13, 2026).
Does MLP Saglik Hizmetleri AS pay a dividend?
MLP Saglik Hizmetleri AS currently shows a dividend yield of about 0.32% relative to its recent price (as of Sep 13, 2026).
What growth is priced into MLP Saglik Hizmetleri AS (MPARK)?
For today's price to be fair in a discounted-cash-flow model, MLP Saglik Hizmetleri AS would have to grow free cash flow by +28.0 % per year for five years (discount rate 15.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +68.9 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of MPARK use?
Our models discount MLP Saglik Hizmetleri AS at 15.7 %: a base by market capitalisation (small), country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For MLP Saglik Hizmetleri AS that is +28.0 % per year a year over ten years, using the same discount rate (15.7 %) and the same formula as our fair value.
How much growth has MLP Saglik Hizmetleri AS (MPARK) delivered so far?
Over the past 5 years revenue at MLP Saglik Hizmetleri AS grew +68.9 % a year. The price currently implies +28.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of MLP Saglik Hizmetleri AS (MPARK) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into MLP Saglik Hizmetleri AS (+28.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of MLP Saglik Hizmetleri AS (MPARK)?
The free-cash-flow yield on the price is 4.10 %: that much free cash flow MLP Saglik Hizmetleri AS produces per unit of market value. When it exceeds the discount rate of our models (15.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of MLP Saglik Hizmetleri AS (MPARK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MLP Saglik Hizmetleri AS it is 639.90 TRY per share (as of Sep 13, 2026), against a price of 438.50 TRY. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is MLP Saglik Hizmetleri AS stock overvalued or undervalued in 2026?
As of Sep 13, 2026, MPARK trades below its calculated fair value: price 438.50 TRY, fair value 639.90 TRY, a gap of about +46% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MPARK?
No. The price is what the market pays today (438.50 TRY); the fair value is what the company's own numbers justify (639.90 TRY). For MLP Saglik Hizmetleri AS the two are 201.40 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is MLP Saglik Hizmetleri AS worth?
The market values MLP Saglik Hizmetleri AS at about 83.5B TRY (market capitalisation, as of Sep 13, 2026). Per share that is 438.50 TRY; our models calculate a fair value of 639.90 TRY per share.
What do the bullish and bearish scenarios say about MPARK?
Our models span a range for MLP Saglik Hizmetleri AS: cautious scenario 291.12 TRY, base 639.90 TRY, optimistic 799.88 TRY per share (as of Sep 13, 2026, price 438.50 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MPARK?
MLP Saglik Hizmetleri AS trades at a price-to-earnings ratio of 13.5 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 639.90 TRY is built from several models across several years. Other multiples: P/B 2.2, P/S 1.4, EV/EBITDA 5.2.
How solid is the balance sheet of MLP Saglik Hizmetleri AS (MPARK)?
Balance-sheet figures for MLP Saglik Hizmetleri AS (as of Sep 13, 2026): return on equity 20.6%, debt of 0.32 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is MPARK from its 52-week high?
MLP Saglik Hizmetleri AS trades at 438.50 TRY, about 15% below its 52-week high of 514.00 TRY and 44% above the low of 304.00 TRY (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 639.90 TRY is for.
Which stocks are comparable to MLP Saglik Hizmetleri AS?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MLP Saglik Hizmetleri AS stock attractive at the current price?
The data as of Sep 13, 2026: price 438.50 TRY, calculated fair value 639.90 TRY (+46%), Quality Score 49/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MPARK calculated?
We run MLP Saglik Hizmetleri AS through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 639.90 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.6 % above its aggregate fair value. MLP Saglik Hizmetleri AS currently trades 46 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MLP Saglik Hizmetleri AS (MPARK)?
The closing price on Sep 14, 2026 was 438.50 TRY. Our model-based fair value is 639.90 TRY, about +46% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MLP Saglik Hizmetleri AS right now?
The model range is unusually wide (291.12 TRY to 799.88 TRY). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (49/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of MLP Saglik Hizmetleri AS
How large is the market capitalisation of MLP Saglik Hizmetleri AS (MPARK)?
The market capitalisation of MLP Saglik Hizmetleri AS is 83.5B TRY (≈ $1.7B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MLP Saglik Hizmetleri AS (MPARK)?
The price-to-sales ratio of MLP Saglik Hizmetleri AS is 1.35 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MLP Saglik Hizmetleri AS (MPARK)?
Earnings per share at MLP Saglik Hizmetleri AS are 29.72 TRY (price ÷ EPS = P/E 13.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of MLP Saglik Hizmetleri AS (MPARK)?
The dividend yield of MLP Saglik Hizmetleri AS is 0.3% (payout 4.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of MLP Saglik Hizmetleri AS (MPARK)?
The net margin of MLP Saglik Hizmetleri AS is 10.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MLP Saglik Hizmetleri AS (MPARK)?
The return on equity (ROE) of MLP Saglik Hizmetleri AS is 20.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MLP Saglik Hizmetleri AS (MPARK)?
On an EBIT basis the return on assets of MLP Saglik Hizmetleri AS is 17.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MLP Saglik Hizmetleri AS (MPARK)?
The operating margin of MLP Saglik Hizmetleri AS is 15.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MLP Saglik Hizmetleri AS (MPARK)?
Revenue at MLP Saglik Hizmetleri AS is growing +5.7% versus a year earlier (3y avg +77.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MLP Saglik Hizmetleri AS (MPARK)?
Earnings per share at MLP Saglik Hizmetleri AS are growing +8.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does MLP Saglik Hizmetleri AS (MPARK) carry?
The net debt of MLP Saglik Hizmetleri AS is 4.8B TRY (fiscal year 2025, ≈ 1.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch MLP Saglik Hizmetleri AS in the live analysis
One click puts MLP Saglik Hizmetleri AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
